Literature DB >> 11934683

Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.

Patricia Iozzo1, Panithaya Chareonthaitawee, Marco Di Terlizzi, D John Betteridge, Ele Ferrannini, Paolo G Camici.   

Abstract

We investigated the effect of insulin on total and regional myocardial blood flow (MBF) and glucose uptake (MGU) in healthy subjects (50 +/- 5 yr) by means of positron emission tomography (PET) with oxygen-15-labeled water (H(2)(15)O) and fluorine-18 labeled fluorodeoxyglucose ((18)FDG) before and during physiological hyperinsulinemia (40 mU.min(-1).m(-2)). Twelve male subjects were included in the study. During hyperinsulinemia, MBF increased from 0.91 +/- 0.28 to 1.01 +/- 0.31 ml.min(-1).g(-1) (n = 7 patients, P = 0.05; n = 112 regions, P < 0.005). Intersubject variability ranged from -3.0 to +41%. MGU increased from 0.11 +/- 0.08 (n = 5) to 0.56 +/- 0.08 micromol.min(-1).g(-1) (P < 0.0001, n = 7). MBF and insulin-mediated MGU were higher in the septum and anterior and lateral wall along short-axis regions of the heart. During hyperinsulinemia, MBF was also higher in the apex and midventricle compared with the base. MBF and MGU were positively correlated before (r = 0.66, P < 0.0001) and during hyperinsulinemia (r = 0.24, P < 0.05). These results provide evidence that insulin stimulates MBF in normal human hearts and appears to involve mainly those regions of the heart where insulin-mediated MGU is higher. Furthermore, regional distribution of insulin-stimulated MBF and MGU does not appear to be uniform across the left ventricular wall of healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934683     DOI: 10.1152/ajpendo.00386.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  15 in total

1.  The effect of insulin on the heart : Part 1: Effects on metabolism and function.

Authors:  L J Klein; F C Visser
Journal:  Neth Heart J       Date:  2010-04       Impact factor: 2.380

2.  Imaging Findings and Literature Review of (18)F-FDG PET/CT in Primary Systemic AL Amyloidosis.

Authors:  Joo Hee Lee; Ga Yeon Lee; Seok Jin Kim; Ki Hyun Kim; Eun-Seok Jeon; Kyung-Han Lee; Byung-Tae Kim; Joon Young Choi
Journal:  Nucl Med Mol Imaging       Date:  2015-05-13

3.  Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis.

Authors:  Roderick Tung; Brenton Bauer; Heinrich Schelbert; Joseph P Lynch; Martin Auerbach; Pawan Gupta; Christiaan Schiepers; Samantha Chan; Julie Ferris; Martin Barrio; Olujimi Ajijola; Jason Bradfield; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2015-08-10       Impact factor: 6.343

4.  Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans.

Authors:  Jia Liu; Linda A Jahn; Dale E Fowler; Eugene J Barrett; Wenhong Cao; Zhenqi Liu
Journal:  J Clin Endocrinol Metab       Date:  2010-11-03       Impact factor: 5.958

Review 5.  The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow.

Authors:  Ines Valenta; Vasken Dilsizian; Alessandra Quercioli; Heinrich R Schelbert; Thomas H Schindler
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 6.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

Review 7.  Radionuclide imaging of myocardial metabolism.

Authors:  Linda R Peterson; Robert J Gropler
Journal:  Circ Cardiovasc Imaging       Date:  2010-03       Impact factor: 7.792

8.  Effect of prolonged fasting and low molecular weight heparin or warfarin therapies on 2-deoxy-2-[18F]-fluoro-D-glucose PET cardiac uptake.

Authors:  Assuero Giorgetti; Gavino Marras; Dario Genovesi; Elena Filidei; Antonio Bottoni; Maurizio Mangione; Michele Emdin; Paolo Marzullo
Journal:  J Nucl Cardiol       Date:  2017-02-03       Impact factor: 5.952

9.  Myocardial glucose uptake in patients with the m.3243A > G mutation in mitochondrial DNA.

Authors:  Markus M Lindroos; Jussi P Pärkkä; Markku T Taittonen; Patricia Iozzo; Mikko Kärppä; Ilmo E Hassinen; Juhani Knuuti; Pirjo Nuutila; Kari Majamaa
Journal:  J Inherit Metab Dis       Date:  2015-06-26       Impact factor: 4.982

10.  Kinetic analysis of FDG in rat liver: effect of dietary intervention on arterial and portal vein input.

Authors:  Sudheer D Rani; Samuel T Nemanich; Nicole Fettig; Kooresh I Shoghi
Journal:  Nucl Med Biol       Date:  2013-02-28       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.